Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Pulmobiotics Engineered Live Biotherapeutic
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Pulmobiotics’ engineered live biotherapeutic significantly reduced antibiotic-resistant pseudomonas aeruginosa infections in the lungs of mice, improving survival rates, and dissolved biofilms formed on endotracheal tubes of patients with VAP.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 19, 2023
Lead Product(s) : Pulmobiotics Engineered Live Biotherapeutic
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable